Breaking News

June 27: Senate Finance Committee to Hold Hearing on Medicare Part B Demonstration

Testifying to the full committee will be Dr. Patrick Conway, Acting Principal Deputy Administrator, Deputy Administrator For Innovation And Quality, And Chief Medical Officer, Centers For Medicare & [...]

June 27: PWC Medical Cost Trend Report Puts Prescription Drug Spending in Perspective

Drug spending at 17% of employer costs while hospital spending accounts for roughly half of spending. Read Full Article Here  

June 27: We’re in the middle of a cancer-treatment revolution — here’s what’s keeping us from beating the disease

With success stories like President Jimmy Carter, who declared he was cancer-free only a few months after sharing that he'd been diagnosed with metastatic melanoma, [...]

Thoughts From COA

June 17: COA Statement on MedPAC June, 2016 Report to Congress

“MedPAC has issued another tone-deaf report on Medicare cancer drug reimbursement to Congress. It completely ignores the obvious and dramatic [...]

No Official Delay to the CMS Part B Experiment

There is no delay to the CMS Part B experiment that we know of officially. The 2019 date simply refers [...]

COA Board Member Testifies Before Congress on Medicare Cancer Experiment

Today COA board member Debra Patt, MD, MPH, MBA, Vice President, Texas Oncology, Medical Director, The US Oncology Network, Chair, [...]

READ MORE
READ MORE

Featured

Milliman Study

A Retrospective Analysis of Medicare and Commercially Insured Claim Data 2004-2014

A Video from Joan Lunden

A Conversation with Joan Lunden On Community Oncology

2017 Community Oncology Conference

April 27-28
Gaylord National Resort & Convention Center

COA Initiatives